Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cardiac Arrhythmia Network of Canada (CANet) is a pan-Canadian patient-centric network of investigators, patients, and healthcare providers dedicated to transforming arrhythmia care. Established in 2014 as a Network of Centres of Excellence, CANet focuses on developing and implementing innovative digital health solutions to reduce sudden cardiac death and improve the management of atrial fibrillation and syncope. Their flagship technology, the VIRTUES platform, is a cloud-based digital health ecosystem that enables remote monitoring and personalized care delivery. By integrating research with clinical practice, CANet aims to improve patient outcomes and reduce healthcare costs across the Canadian healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiac Arrhythmia Network of Canada.